Bibek Paudel point us to a BusinessWeek report on Google’s interest in the cataloging and examining of people’s DNA. Google has recently invested in DNA screening firms Navigenics and 23andMe, which test customers’ DNA for characteristics such as ancestry and predisposition for certain diseases. The customers are then able to give the information to their physicians. This isn’t Google’s first foray into the medical industry. “Google wants to plant an early stake in a potentially big new market around genetic data. ‘We are interested in supporting companies and making investments in companies that [bolster] our mission statement, which is organizing the world’s information and making it universally accessible and useful,’ Google spokesman Andrew Pederson states. ‘We felt it was important to get involved now, at the early stage, to superior comprehend the information generated by this fast-moving field.’”
Read more of this story at Slashdot.
Entries (RSS)